Evidence map›Paper›PMID 27505032›Full record

ArticleBiochemistry2016

Chaperonin-Based Biolayer Interferometry To Assess the Kinetic Stability of Metastable, Aggregation-Prone Proteins.

Wendy A Lea, Pierce T O'Neil, Alexandra J Machen, Subhashchandra Naik, Tapan Chaudhri, Wesley McGinn-Straub, Alexander Tischer, Matthew T Auton, Joshua R Burns, Michael R Baldwin and 3 more

Abstract read
In one paragraph

Article in Biochemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Rheostatic contributions to protein stability can obscure a position's functional role.Protein science : a publication of the Protein Society · 2024
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 2 countries.

Wendy A LeaDepartment of Biochemistry and Molecular Biology, University of Kansas Medical Center , Kansas City, Kansas 66160, United States.
Pierce T O'NeilDepartment of Biochemistry and Molecular Biology, University of Kansas Medical Center , Kansas City, Kansas 66160, United States.
Alexandra J MachenDepartment of Biochemistry and Molecular Biology, University of Kansas Medical Center , Kansas City, Kansas 66160, United States.
Subhashchandra NaikDepartment of Biochemistry and Molecular Biology, University of Kansas Medical Center , Kansas City, Kansas 66160, United States.
Tapan ChaudhriIndian Institute of Technology , Delhi, India.
Wesley McGinn-StraubfortéBIO (a division of Pall Life Sciences) , Menlo Park, California 94025, United States.
Alexander TischerDivision of Hematology, Department of Internal Medicine, Mayo Clinic , Rochester, Minnesota 55902, United States.
Matthew T AutonDivision of Hematology, Department of Internal Medicine, Mayo Clinic , Rochester, Minnesota 55902, United States.
Joshua R BurnsDepartment of Molecular Microbiology and Immunology, University of Missouri , Columbia, Missouri 65212, United States.
Michael R BaldwinDepartment of Molecular Microbiology and Immunology, University of Missouri , Columbia, Missouri 65212, United States.
Karen R KharCenter for Computational Biology and Department of Molecular Biosciences, University of Kansas , Lawrence, Kansas 66045, United States.
John KaranicolasCenter for Computational Biology and Department of Molecular Biosciences, University of Kansas , Lawrence, Kansas 66045, United States.
Mark T FisherDepartment of Biochemistry and Molecular Biology, University of Kansas Medical Center , Kansas City, Kansas 66160, United States.
University of Kansas Medical Center · USMayo Clinic · USUniversity of Kansas · USUniversity of Missouri · USIndian Institute of Technology Delhi · INMenlo School · US

Funding

Mentoring CoreP20GM103418 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI SUSAN J. BROWN · 2012 to 2026
$63.0M
PHARMACEUTICAL ASPECTS OF BIOTECHNOLOGY TRAININGT32GM008359 · NIGMS · UNIVERSITY OF KANSAS LAWRENCE · PI SIAHAAN, TERUNA J., VOLKIN, DAVID · 1989 to 2018
$5.0M
Thermodynamics of the Conformational Activation of Von Willebrand FactorR01HL109109 · NHLBI · MAYO CLINIC ROCHESTER · PI AUTON, MATTHEW · 2011 to 2015
$1.7M
CryoEM analysis of Anthrax Toxin Pore ComplexesR01AI090085 · NIAID · UNIVERSITY OF KANSAS MEDICAL CENTER · PI FISHER, MARK T · 2011 to 2013
$948k
Graduate Training Program in Multidimensional VaccinogenesisT32AI070089 · NIAID · UNIVERSITY OF KANSAS LAWRENCE · PI VOLKIN, DAVID · 2007 to 2011
$477k
NHLBI NIH HHS R01 HL109109NIAID NIH HHS R01 AI090085NIAID NIH HHS T32 AI070089NIGMS NIH HHS P20 GM103418NIGMS NIH HHS T32 GM008359
6 · The paper itself

Abstract

Stabilizing the folded state of metastable and/or aggregation-prone proteins through exogenous ligand binding is an appealing strategy for decreasing disease pathologies caused by protein folding defects or deleterious kinetic transitions. Current methods of examining binding of a ligand to these marginally stable native states are limited because protein aggregation typically interferes with analysis. Here, we describe a rapid method for assessing the kinetic stability of folded proteins and monitoring the effects of ligand stabilization for both intrinsically stable proteins (monomers, oligomers, and multidomain proteins) and metastable proteins (e.g., low Tm) that uses a new GroEL chaperonin-based biolayer interferometry (BLI) denaturant pulse platform. A kinetically controlled denaturation isotherm is generated by exposing a target protein, immobilized on a BLI biosensor, to increasing denaturant concentrations (urea or GuHCl) in a pulsatile manner to induce partial or complete unfolding of the attached protein population. Following the rapid removal of the denaturant, the extent of hydrophobic unfolded/partially folded species that remains is detected by an increased level of GroEL binding. Because this kinetic denaturant pulse is brief, the amplitude of binding of GroEL to the immobilized protein depends on the duration of the exposure to the denaturant, the concentration of the denaturant, wash times, and the underlying protein unfolding-refolding kinetics; fixing all other parameters and plotting the GroEL binding amplitude versus denaturant pulse concentration result in a kinetically controlled denaturation isotherm. When folding osmolytes or stabilizing ligands are added to the immobilized target proteins before and during the denaturant pulse, the diminished population of unfolded/partially folded protein manifests as a decreased level of GroEL binding and/or a marked shift in these kinetically controlled denaturation profiles to higher denaturant concentrations. This particular platform approach can be used to identify small molecules and/or solution conditions that can stabilize or destabilize thermally stable proteins, multidomain proteins, oligomeric proteins, and, most importantly, aggregation-prone metastable proteins.

Indexed as

Biosensing TechniquesChaperonin 60KineticsLigandsProtein DenaturationProtein FoldingProteinsThermodynamicsChaperonin 60LigandsProteins

Identifiers

PMID27505032
PMCPMC5524994
OpenAlexW2491536631

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.